section name header

Pronunciation

klin-da-MYE-sin/TRET-i-noin

Classifications

Therapeutic Classification: antiacne agents

Pharmacologic Classification: lincosamides, retinoids

Indications

REMS


Action

  • Clindamycin: interferes with bacterial protein synthesis.
  • Tretinoin: decreases microcomedome formation and extrusion of comedomes.
  • Clindamycin is active against Propionibacterium acnes.
Therapeutic effects:
  • Decreased severity of acne.

Pharmacokinetics

Absorption: Some absorption of clindamycin follows topical administration.

Distribution: Unknown.

Metabolism/Excretion: Unknown.

Half-Life: Unknown.

Time/Action Profile

(improvement in acne)

ROUTEONSETPEAKDURATION
Topicaldays-wksunknownunknown



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Derm: photosensitivity

GI: COLITIS, diarrhea

Local: burning, dryness, scaling, dermatitis, erythema, exfoliation, irritation, pruritus, sunburn

Interactions

Drug-drug:

Route/Dosage

Availability

Assessment

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Veltin